A team of World Health Organization experts arrived in Wuhan, central China on Thursday to investigate the cause of the COVID-19 pandemic.
An international team of 10 jumped into Wuhan after a direct flight from Singapore and soon entered a 14-day quarantine period. Two other members of the WHO team remained in Singapore after being tested positive for the COVID-19 antibody, according to a series of tweets from authorities.
They were tested again in #Singapore And all were negative for PCR. However, two members tested positive for IgM antibodies. It has been retested for both IgM and IgG antibodies. https: //t.co/3Yg9UoZ1mx
— World Health Organization (WHO) (@ WHO) January 14, 2021
According to the Johns Hopkins University Coronavirus Resource Center, the virus was first detected in Wuhan in late 2019 and eventually spread to almost everywhere in the world, with more than 1.9 million out of more than 92.3 million infections. Died.
WHO Secretary-General Tedros Adhanom Gebreyes expressed “disappointment” to China last week after Beijing did not finally grant a delegation’s entry permit, although the plan was jointly coordinated between the two countries. Beijing defended this delay as a “misunderstanding.”
The arrival of the team came when China reported the death of the first new COVID-19 since May last year. This is part of a surge in new coronavirus infections in Hebei and northern Heilongjiang provinces. The National Health Commission reported 138 new cases on Thursday. This is an increase from 115 new cases posted the day before, Hebei has recorded 81 new cases, and 43 have come from Heilongjiang. The other 14 came from abroad.
Hebei officials have blocked several cities due to the surge in new infections, and officials in northeastern Heilongjiang have declared a “state of emergency” for the entire state and its 37 million inhabitants. ..
The world seems to be on the verge of another effective COVID-19 vaccine.Study published on Wednesday New England Journal of Medicine An experimental vaccine developed by Johnson & Johnson was found in early-stage trials to provoke a strong immune response in both young and older volunteer participants.
Unlike vaccines developed by Pfizer-BioNTech and Moderna, Johnson & Johnson vaccines require a single dose, facilitating both long-term transport and refrigeration. The vaccine is currently undergoing a late-stage trial involving 45,000 volunteers. Johnson & Johnson will seek an emergency use authorization from the US Food and Drug Administration later next month.
The company has a $ 1 billion contract with the US government to provide up to 100 million doses of vaccine once approved.
WHO experts arrive in China to investigate the origin of the pandemic | Voice of America
Source link WHO experts arrive in China to investigate the origin of the pandemic | Voice of America